Allergy season arrived early in US. Here's how to keep pollen from ruining spring
Allergy season in the U.S. is starting sooner than experts expected (Source: ABC News: Health)
Source: ABC News: Health - March 22, 2024 Category: Consumer Health News Tags: Health Source Type: news
Removal of penicillin allergy labels can be done safely
It is likely to be safe for penicillin allergy labels (PALs) to be removed for most patients, a study has found. Patients who thought they had an allergy to penicillin and who were deemed low risk took part in ‘penicillin challenges’, where a small dose of penicillin was given instead of allergy testing. Ninety-seven per... Read moreThe post Removal of penicillin allergy labels can be done safely appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - March 21, 2024 Category: Nursing Authors: Carolyn Scott Tags: Allergy Vaccinations and infections pencillin allergy Source Type: news
Bypassing Oral Immunotherapy Buildup Safe in Children With Food Allergy
THURSDAY, March 21, 2024 -- An initial phase of multifood sublingual immunotherapy (SLIT) that bypasses oral immunotherapy (OIT) buildup is safe and effective, according to a study published online Feb. 27 in the Journal of Allergy and Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2024 Category: Pharmaceuticals Source Type: news
Immunomodulators Do Not Affect COVID-19 Vaccine Efficacy Immunomodulators Do Not Affect COVID-19 Vaccine Efficacy
A study suggested that immunomodulatory medications do not increase the risk for COVID-19 related hospitalizations in patients who have received the COVID-19 vaccine.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 21, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news
Benralizumab Proves Effective for Eosinophilic Granulomatosis With Polyangiitis
(MedPage Today) -- At the recent American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, researchers reported that treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for relapsing or refractory eosinophilic... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 20, 2024 Category: Allergy & Immunology Source Type: news
Getting Reluctant Patients to'Yes' on COVID Vaccination Getting Reluctant Patients to'Yes' on COVID Vaccination
Five useful tips for helping the vax-hesitant people get past their objections.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 20, 2024 Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news
Column: Two Rutgers professors are accused of poisoning the debate over COVID's origins. Here's why
The former head of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, has been the target of noxious attacks over COVID-19’s origins. In a Dec. 2 tweet, Richard H. Ebright, a professor of chemistry and chemical biology at Rutgers University, stated that Anthony Fauci,…#anthonyfauci #richardhebright #rutgersuniversity #fauci #cambodian #polpot #ebright #brycenickels #angelarasmussen #michaelworobey (Source: Reuters: Health)
Source: Reuters: Health - March 20, 2024 Category: Consumer Health News Source Type: news
Infants ’ Gut Bacteria Create Serotonin To Build A Robust Immune System
The bacteria that colonize a newborn child ’s gut play a critical role in building a robust immune system, especially for preventing food allergies. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 20, 2024 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
Patients With Sj ögren Syndrome Fall Into Distinct Subgroups Patients With Sj ögren Syndrome Fall Into Distinct Subgroups
Those with high systemic disease activity but low symptom burden fared worse over time.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 20, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
Mayo Clinic Minute: Spring pollen and allergy tips
If you are one of the millions of people who suffer pollen and allergies, you don't need a calendar to tell you that spring has started. Sometimes called hay fever, allergic rhinitis can sometimes be confused with a cold. So, what's happening and what can you do? While hay fever alone may not be life threatening, it can be uncomfortable, says Dr. Arveen Bhasin, a Mayo Clinic allergy and immunology expert. She offers these tips for relief from spring… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 20, 2024 Category: Databases & Libraries Source Type: news
Roflumilast Cream Quickly Improved AD in Children, Ages 2-5 Roflumilast Cream Quickly Improved AD in Children, Ages 2-5
Among patients treated with roflumilast cream, 0.05%, 25.4% reached the primary endpoint of " clear " or " almost clear " plus a two-grade improvement from baseline at week 4.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 19, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news
Children with allergies 'put at risk by schools'
The family of a five-year-old who died after collapsing at school is calling for more legislation. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 19, 2024 Category: Consumer Health News Source Type: news
AstraZeneca to Cap Out-of-pocket Inhaler Costs in US, Following Rival Boehringer's Move AstraZeneca to Cap Out-of-pocket Inhaler Costs in US, Following Rival Boehringer's Move
Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, following a...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 19, 2024 Category: Allergy & Immunology Tags: Pulmonary Medicine Source Type: news
First Treatment Approved for Chronic Rhinosinusitis Without Nasal Polyps
(MedPage Today) -- The FDA expanded the approval of fluticasone propionate (Xhance) nasal spray for chronic rhinosinusitis to also include treatment of adults without nasal polyps, manufacturer Optinose announced on Friday.
The drug-device combination... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 19, 2024 Category: Allergy & Immunology Source Type: news
AstraZeneca Follows Rival Boehringer in Capping Out-of-pocket Costs for Inhalers AstraZeneca Follows Rival Boehringer in Capping Out-of-pocket Costs for Inhalers
Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States, following a similar move by...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 18, 2024 Category: Allergy & Immunology Tags: Pulmonary Medicine Source Type: news
